首页> 美国卫生研究院文献>Cancer Science >Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
【2h】

Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth

机译:旨在破坏TMPRSS2中融合位点的吡咯咪唑聚酰胺和ERG基因融合抑制前列腺肿瘤的生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aberrant overexpression of ERG induced by the TMPRSS2-ERG gene fusion is likely involved in the development of prostate cancer. Synthetic pyrrole–imidazole (PI) polyamides recognize and attach to the minor groove of DNA with high affinity and specificity. In the present study, we designed a PI polyamide targeting TMPRSS2-ERG translocation breakpoints and assessed its effect on human prostate cancer cells. Our study identified that this PI polyamide repressed the cell and tumor growth of androgen-sensitive LNCaP prostate cancer cells. Targeting of these breakpoint sequences by PI polyamides could be a novel approach for the treatment of prostate cancer.
机译:由TMPRSS2-ERG基因融合诱导的ERG异常过表达可能与前列腺癌的发展有关。合成吡咯-咪唑(PI)聚酰胺能够以高亲和力和特异性识别并附着在DNA的细小凹槽上。在本研究中,我们设计了靶向TMPRSS2-ERG易位断点的PI聚酰胺,并评估了其对人前列腺癌细胞的作用。我们的研究发现,这种PI聚酰胺可抑制雄激素敏感性LNCaP前列腺癌细胞的细胞和肿瘤生长。 PI聚酰胺靶向这些断点序列可能是治疗前列腺癌的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号